Real-world efficacy and safety of anlotinib combined with chemotherapy for advanced pancreatic cancer: a retrospective study
Background Pancreatic cancer (PC) is often diagnosed at advanced stages, limiting surgical options. There is no standardized treatment for second-line or beyond therapies, necessitating alternative treatments. This study evaluates the efficacy and safety of anlotinib combined with chemotherapy in ad...
Saved in:
| Main Authors: | Zhiyong Li, Zhiming Wang, Hexia Gan, Feng Shen, Lisha Cheng, Xiuping Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Future Science OA |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/20565623.2025.2532327 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of programmed death-1 inhibitors combined with chemotherapy in patients with advanced gastric cancer
by: Xiaofei Cheng, et al.
Published: (2025-08-01) -
Case Report: Cadonilimab plus anlotinib with radiotherapy for lung adenocarcinoma with pancreatic metastasis in later-line therapy
by: Jianquan Yang, et al.
Published: (2025-07-01) -
Risk Factors for Prognosis of Lung Cancer Patients Receiving Anlotinib Treatment: A Retrospective Cohort Study
by: Congyi Xie, et al.
Published: (2025-02-01) -
Cost-effectiveness analysis of benmelstobart, anlotinib, and chemotherapy in extensive-stage small-cell lung cancer
by: Maojin You, et al.
Published: (2024-11-01) -
A phase II study of anlotinib plus whole brain radiation therapy for patients with NSCLC with multiple brain metastases
by: Dayong Gu, et al.
Published: (2024-12-01)